1. Acute Hemodynamic Effects of Pacing in Patients Supported by a Heartmate 3 Durable Left Ventricular Assist Device.
- Author
-
Akdogan RE, Silverman D, Rofael M, Fu S, Kozaily E, Atkins J, Jackson GR, Inampudi C, Griffin JM, Rao VN, Gregoski MJ, Hajj JM, Winterfield JR, Kilic A, Houston BA, Tedford RJ, and Carnicelli AP
- Subjects
- Humans, Male, Middle Aged, Female, Cardiac Pacing, Artificial, Ventricular Function, Left physiology, Aged, Treatment Outcome, Heart-Assist Devices, Heart Failure physiopathology, Heart Failure therapy, Hemodynamics physiology
- Abstract
Competing Interests: Dr Carnicelli reports research support from Acorai. Dr Hajj reports consulting for Abbott and Medtronic. Dr Kilic reports speaker/consultant fees from Abbott, Abiomed, 3ive, and LivaNova. Dr Tedford reports no direct conflicts of interest related to this article. He is co-chair of the Pulmonary Hypertension Due to Left Heart Disease Task Force for Seventh World Symposium on Pulmonary Hypertension. He reports general disclosures to include consulting relationships with Abbott, Acorai, Aria CV Inc, Acceleron/Merck, Alleviant, Boston Scientific, Cytokinetics, Edwards LifeSciences, Endotronix, Gradient, Medtronic, Morphic Therapeutics, Restore Medical, and United Therapeutics. Dr Tedford serves on steering committee for Merck, Edwards, Endotronix, and Abbott as well as a research advisory board for Abiomed. He also does hemodynamic core laboratory work for Merck. The other authors report no relevant disclosures.
- Published
- 2024
- Full Text
- View/download PDF